Michelle Lockley
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 22
- CAR-T cell therapy research 6
-
- RNA Interference and Gene Delivery 5
- CRISPR and Genetic Engineering 5
- Co-authors
- Iain A. McNeish (20 shared papers)Frances R. Balkwill (9 shared papers)Darren Ennis (8 shared papers)Steffen Böhm (5 shared papers)Thomas Dowe (3 shared papers)Heidi H. Swanson (1 shared paper)Nicholas R. Lemoine (4 shared papers)Naveena Singh (6 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (6 papers)International Journal of Gynecological Cancer (5 papers)Clinical Cancer Research (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Michelle Lockley
61 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 94
- Reproductive Medicine 395
- Oncology 579
- Immunology 346
- Genetics 337
- Cancer Research 155
Countries citing papers authored by Michelle Lockley
This map shows the geographic impact of Michelle Lockley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Lockley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Lockley more than expected).
Fields of papers citing papers by Michelle Lockley
This network shows the impact of papers produced by Michelle Lockley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Lockley. The network helps show where Michelle Lockley may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Lockley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 199 | |
| 2 | 2016 | 177 | |
| 3 | 2016 | 155 | |
| 4 | 2016 | 111 | |
| 5 | 2023 | 66 | |
| 6 | 2007 | 64 | |
| 7 | 1978 | 59 | |
| 8 | 2012 | 51 | |
| 9 | 2006 | 49 | |
| 10 | 2004 | 46 | |
| 11 | 2019 | 42 | |
| 12 | 2018 | 39 | |
| 13 | 2012 | 39 | |
| 14 | 2018 | 39 | |
| 15 | 2012 | 35 | |
| 16 | 2021 | 34 | |
| 17 | 2022 | 30 | |
| 18 | 2014 | 30 | |
| 19 | 1986 | 28 | |
| 20 | 2016 | 26 |
About Michelle Lockley
Michelle Lockley is a scholar working on Oncology, Molecular Biology, Reproductive Medicine, Genetics and Surgery, having authored 64 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (15 papers), Testicular diseases and treatments (13 papers), Virus-based gene therapy research (11 papers), CAR-T cell therapy research (6 papers), RNA Interference and Gene Delivery (5 papers), Cancer Genomics and Diagnostics (5 papers), CRISPR and Genetic Engineering (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Reproductive Medicine (395 citations), Oncology (579 citations), Immunology (346 citations), Genetics (337 citations) and Cancer Research (155 citations). Michelle Lockley has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Iain A. McNeish, Frances R. Balkwill, Darren Ennis, Steffen Böhm, Thomas Dowe, Heidi H. Swanson, Nicholas R. Lemoine, Naveena Singh, Asma Faruqi and Oliver M.T. Pearce. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, International Journal of Gynecological Cancer, Clinical Cancer Research and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.